Often forming heterodimers, S100A8 and S100A9 serve as biomarkers for the diagnosis and therapeutic responses in inflammatory diseases like inflammatory arthritis and inflammatory bowel disease, while blocking their activity resulted in reduced inflammation in mouse models (Wang et al., 2018). This evidence concerns the gene S100A9 and inflammatory bowel disease.